Tower Research Capital (TRC)’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.27K | Sell |
10,277
-240
| -2% | -$100 | ﹤0.01% | 4352 |
|
|
2025
Q1 | $6.55K | Buy |
10,517
+5,516
| +110% | +$3.44K | ﹤0.01% | 4033 |
|
|
2024
Q4 | $8.35K | Sell |
5,001
-2,346
| -32% | -$3.92K | ﹤0.01% | 3998 |
|
|
2024
Q3 | $13.4K | Sell |
7,347
-232
| -3% | -$422 | ﹤0.01% | 3520 |
|
|
2024
Q2 | $45.7K | Buy |
7,579
+2,833
| +60% | +$17.1K | ﹤0.01% | 3177 |
|
|
2024
Q1 | $52.9K | Sell |
4,746
-2,815
| -37% | -$31.4K | ﹤0.01% | 2238 |
|
|
2023
Q4 | $113K | Buy |
7,561
+4,120
| +120% | +$61.3K | ﹤0.01% | 2561 |
|
|
2023
Q3 | $16.5K | Buy |
3,441
+1,166
| +51% | +$5.6K | ﹤0.01% | 3553 |
|
|
2023
Q2 | $17.1K | Sell |
2,275
-11,419
| -83% | -$85.8K | ﹤0.01% | 3501 |
|
|
2023
Q1 | $62K | Buy |
13,694
+12,473
| +1,022% | +$56.5K | ﹤0.01% | 2306 |
|
|
2022
Q4 | $13K | Sell |
1,221
-7,979
| -87% | -$85K | ﹤0.01% | 3570 |
|
|
2022
Q3 | $88K | Buy |
9,200
+2,110
| +30% | +$20.2K | ﹤0.01% | 2667 |
|
|
2022
Q2 | $57K | Buy |
7,090
+4,226
| +148% | +$34K | ﹤0.01% | 2755 |
|
|
2022
Q1 | $48K | Sell |
2,864
-1,413
| -33% | -$23.7K | ﹤0.01% | 2754 |
|
|
2021
Q4 | $92K | Buy |
4,277
+2,852
| +200% | +$61.3K | ﹤0.01% | 2279 |
|
|
2021
Q3 | $105K | Sell |
1,425
-205
| -13% | -$15.1K | ﹤0.01% | 2354 |
|
|
2021
Q2 | $89K | Buy |
1,630
+869
| +114% | +$47.4K | ﹤0.01% | 2518 |
|
|
2021
Q1 | $56K | Sell |
761
-612
| -45% | -$45K | ﹤0.01% | 3023 |
|
|
2020
Q4 | $118K | Sell |
1,373
-210
| -13% | -$18K | ﹤0.01% | 2185 |
|
|
2020
Q3 | $60K | Buy |
+1,583
| New | +$60K | ﹤0.01% | 3455 |
|